NFH
RGLS

NEXT Financial Holdings’s Regulus Therapeutics RGLS Stock Holding History

NEXT Financial Holdings’s Portfolio RGLS Stock Details RGLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$0 Buy
+5
New +$54 ﹤0.01% 1673

Other funds holding RGLS

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NEXT Financial Holdings's RGLS Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Regulus Therapeutics (RGLS) in Q1 2019: 5 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1673 among its holdings.

28 funds tracked by Wall St. Rank hold RGLS as of Q1 2019.

  • NEXT Financial Holdings held 5 shares of Regulus Therapeutics worth $0 as of Q1 2019.
  • Regulus Therapeutics was a new NEXT Financial Holdings position in Q1 2019.
  • Regulus Therapeutics made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1673 holding.
  • 28 funds tracked by Wall St. Rank held Regulus Therapeutics as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.